Priority 14 from the Juvenile Idiopathic Arthritis (Netherlands) PSP
| UNCERTAINTY: How can pain best be recognised and be treated (with medication), and what action can a patient take him/herself? (JLA PSP Priority 14) | |
|---|---|
| Overall ranking | 14 |
| JLA question ID | 0094/14 |
| Explanatory note | This questions asks about the management of pain in JIA. Respondents wanted to know how it can best be recognised and treated, and what one can do oneself to minimise pain. |
| Evidence |
Systematic review - Eccleston et al. Non-steroidal anti-inflammatory drugs for chronic non-cancer pain in children and adolescents. Cochrane Database Syst Rev 2017;8. Systematic review - Jennings et al. The clinical effectiveness of intra-articular corticosteroids for arthritis of the lower limb in juvenile idiopathic arthritis: a systematic review. Pediatric rheumatology 2014;12. |
| Health Research Classification System category | Inflammatory and immune system |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | See data spreadsheet on JLA website |
| Submitted by | See data spreadsheet on JLA website |
| PSP information | |
|---|---|
| PSP unique ID | 0094 |
| PSP name | Juvenile Idiopathic Arthritis (Netherlands) |
| Total number of uncertainties identified by this PSP | 53 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | 7 February 2020 |